Trial · NCT03381729
Adverse events572
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 572
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Lymphadenopathy | Blood and lymphatic system disorders | Cohort 1: 6.0E13 Vector Genomes (vg) - Age 6 to <24 Months | 0 | 3 | |
| other | Lymphadenopathy | Blood and lymphatic system disorders | Cohort 2: 1.2E14 vg - Age 6 to <24 Months | 2 | 13 | |
| other | Lymphadenopathy | Blood and lymphatic system disorders | Cohort 2: 1.2E14 vg - Age 24 to <60 Months | 1 | 12 | |
| other | Lymphadenopathy | Blood and lymphatic system disorders | Cohort 3: 2.4E14 vg - Age 6 to <24 Months | 0 | 4 | |
| other | Leukopenia | Blood and lymphatic system disorders | Cohort 1: 6.0E13 Vector Genomes (vg) - Age 6 to <24 Months | 0 | 3 | |
| other | Leukopenia | Blood and lymphatic system disorders | Cohort 2: 1.2E14 vg - Age 6 to <24 Months | 1 | 13 | |
| other | Leukopenia | Blood and lymphatic system disorders | Cohort 2: 1.2E14 vg - Age 24 to <60 Months | 0 | 12 | |
| other | Leukopenia | Blood and lymphatic system disorders | Cohort 3: 2.4E14 vg - Age 6 to <24 Months | 0 | 4 | |
| other | Tachycardia | Cardiac disorders | Cohort 1: 6.0E13 Vector Genomes (vg) - Age 6 to <24 Months | 0 | 3 | |
| other | Tachycardia | Cardiac disorders | Cohort 2: 1.2E14 vg - Age 6 to <24 Months | 2 | 13 | |
| other | Tachycardia | Cardiac disorders | Cohort 2: 1.2E14 vg - Age 24 to <60 Months | 2 | 12 | |
| other | Tachycardia | Cardiac disorders | Cohort 3: 2.4E14 vg - Age 6 to <24 Months | 0 | 4 | |
| other | Mitral valve incompetence | Cardiac disorders | Cohort 1: 6.0E13 Vector Genomes (vg) - Age 6 to <24 Months | 0 | 3 | |
| other | Mitral valve incompetence | Cardiac disorders | Cohort 2: 1.2E14 vg - Age 6 to <24 Months | 1 | 13 | |
| other | Mitral valve incompetence | Cardiac disorders | Cohort 2: 1.2E14 vg - Age 24 to <60 Months | 1 | 12 | |
| other | Mitral valve incompetence | Cardiac disorders | Cohort 3: 2.4E14 vg - Age 6 to <24 Months | 0 | 4 | |
| other | Sinus tachycardia | Cardiac disorders | Cohort 1: 6.0E13 Vector Genomes (vg) - Age 6 to <24 Months | 0 | 3 | |
| other | Sinus tachycardia | Cardiac disorders | Cohort 2: 1.2E14 vg - Age 6 to <24 Months | 1 | 13 | |
| other | Sinus tachycardia | Cardiac disorders | Cohort 2: 1.2E14 vg - Age 24 to <60 Months | 1 | 12 | |
| other | Sinus tachycardia | Cardiac disorders | Cohort 3: 2.4E14 vg - Age 6 to <24 Months | 0 | 4 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03381729/events